Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

Clinical trial NCT06376162 · RECRUITING

Trial details

NCT number: NCT06376162
Sponsor: PedAL BCU, LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory KMT2A-r Acute Leukemia Relapsed/Refractory NUP98-r Acute Leukemia Relapsed/Refractory NPM1-m Acute Leukemia

Start date: 2025-03-18
Primary completion: 2027-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.